Ronald B. Herberman

35.2k citations

518 papers · 28.1k indexed · 7 hit papers · h-index 86

Immunology top 0.02%
- Immune Cell Function and Interaction 243
- Immunotherapy and Immune Responses 117
- T-cell and B-cell Immunology 90
- Immune Response and Inflammation 39
- Macrophage Migration Inhibitory Factor 36
Oncology top 0.1%
- CAR-T cell therapy research 33
Biological Psychiatry top 1%
Hematology top 0.5%
Radiology, Nuclear Medicine and Imaging top 0.2%
- Monoclonal and Polyclonal Antibodies Research 70
Genetics
- Virus-based gene therapy research 51

Co-authors: Howard T. Holden John R. Ortaldo Myrthel E. Nunn Theresa L. Whiteside David H. Lavrin Julie Y. Djeu Guy D. Bonnard Holger Kirchner
Cited by: Immunology Oncology Biological Psychiatry
Partner nations: United States Italy Canada

In The Last Decade

Ronald B. Herberman

509 papers receiving 25.4k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1981 Natural Killer Cells: Their Roles in Defenses Against Disease
1979 Natural Killer Cells: Characteristics and Regulation of Activity
1979 Augmentation of Mouse Natural Killer Cell Activity by Interferon and Interferon Inducers
1978 Natural Cell-Mediated Immunity
1977 Natural Cytotoxic Reactivity of Human Lymphocytes Against a Myeloid Cell Line: Characterization of Effector Cells
1975 Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells
1975 Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity

Peers

Countries citing papers authored by Ronald B. Herberman

Since Specialization

Citations

This map shows the geographic impact of Ronald B. Herberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Herberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Herberman more than expected).

Fields of papers citing papers by Ronald B. Herberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Herberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Herberman. The network helps show where Ronald B. Herberman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronald B. Herberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald B. Herberman Line = papers co-authored together Ronald B. Herberman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK) Weiwei Li,Wenna Chen,Ronald B. Herberman,Nicolas P. Plotnikoff,Gene Youkilis,Noreen Griffin,Enhua Wang,Changlong Lu,Fengping Shan	2013	44
2	Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic Frank L. Meyskens,Gregory A. Curt,Dean E. Brenner,Gary Gordon,Ronald B. Herberman,Olivera J. Finn,Gary J. Kelloff,Samir N. Khleif,Caroline C. Sigman,Éva Szabó	2011	36
3	Biological Significance of Prolactin in Gynecologic Cancers Vera Levina,Brian M. Nolen,YunYun Su,Andrew K. Godwin,David A. Fishman,Jinsong Liu,Gil Mor,Larry G. Maxwell,Ronald B. Herberman,Mirosław J. Szczepański,Marta Szajnik,Elieser Gorelik,Anna Lokshin	2009	75
4	Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer Lisheng Ge,Dejan Baskić,Per Basse,Lazar Vujanović,Sebnem Unlu,Toshie Yoneyama,Andrea Vujanovic,Jie Han,Dragić Banković,Mirosław J. Szczepański,Jennifer L. Hunt,Ronald B. Herberman,Susanne M. Gollin,Robert L. Ferris,Theresa L. Whiteside,Eugene N. Myers,Nikola L. Vujanović	2009	18
5	Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor–c-kit Autocrine Signaling Loop Vera Levina,Adele Marrangoni,Tingting Wang,Simul Parikh,Yunyun Su,Ronald B. Herberman,Anna Lokshin,Elieser Gorelik	2009	124
6	Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers Bratislav Janjic,Pedro Andrade,Xiaofei Wang,Julien Fourcade,Christine Almunia,Pavol Kudela,Adam Brufsky,Samuel A. Jacobs,David Friedland,Ronald G. Stoller,Daniel Gillet,Ronald B. Herberman,John M. Kirkwood,Bernard Maillère,Hassane M. Zarour	2006	15
7	Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer Ronald Glaser,David A. Padgett,Monica L. Litsky,Robert A. Baiocchi,Eric V. Yang,Min Chen,Peir‐En Yeh,Nancy G. Klimas,Gailen D. Marshall,Theresa L. Whiteside,Ronald B. Herberman,Janice K. Kiecolt‐Glaser,Marshall V. Williams	2004	99
8	Review of Recent Developments in the Molecular Characterization of Recombinant Alfa Interferons on the 40th Anniversary of the Discovery of Interferon Mark R. Walter,Ronald Bordens,Tattanahalli L. Nagabhushan,Bryan Williams,Ronald B. Herberman,C A Dinarello,Ernest C. Borden,Paul P. Trotta,Sidney Pestka,Lawrence M. Pfeffer	1998	29
9	Dysfunction of Natural Killer Activity in a Family with Chronic Fatigue Syndrome Paul H. Levine,Theresa L. Whiteside,Diana Friberg,John Bryant,Ginga Colclough,Ronald B. Herberman	1998	53
10	Serum and tissue banks for biological markers. Theresa L. Whiteside,Ronald B. Herberman	1990	1
11	Cytotoxic Activity Against HIV-infected Monocytes by Recombinant Interleukin 2-Activated Natural Killer Cells Robert J. Melder,Raghavan Balachandran,Charles R. Rinaldo,Phalguni Gupta,Theresa L. Whiteside,Ronald B. Herberman	1990	19
12	Immunomodulation and antitumor effects of MVE-2 in mice. James E. Talmadge,Annette E. Maluish,Margaret S. Collins,Mark Schneider,Ronald B. Herberman,Robert K. Oldham,Robert H. Wiltrout	1984	15
13	Production of plasminogen activator by human natural killer cells. Large granular lymphocytes. R H Goldfarb,Tuomo Timonen,Ronald B. Herberman	1984	29
14	Interferon Activates Macrophages to Produce Plasminogen Activator C. Michael Jones,Luigi Varesio,Ronald B. Herberman,Sidney Pestka	1982	25
15	Augmentation of Human Natural Killer Cell Activity by Interferon: Conditions Required for Boosting and Characteristics of the Effector Cells John R. Ortaldo,Nicholas P. Lang,Tuomo Timonen,Ronald B. Herberman	1981	15
16	Evaluation of the Role of IgG Antibodies in Human Natural Cell-Mediated Cytotoxicity Against the Myeloid Cell Line K562 H. David Kay,Guy D. Bonnard,Ronald B. Herberman	1979	25
17	Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. Ronald B. Herberman,Howard T. Holden,Chou‐Chik Ting,David L. Lavrin,Holger Kirchner	1976	25
18	Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response. Chou‐Chik Ting,Holger Kirchner,Dennis Rodrigues,Joseph Y. Park,Ronald B. Herberman	1976	22
19	Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition. G D Bonnard,Eric Manders,Darrell A. Campbell,Ronald B. Herberman,Michael J. Collins	1976	110
20	THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES Ronald B. Herberman,Chandler A. Stetson	1965	38

About Ronald B. Herberman

Ronald B. Herberman is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 518 papers that have together received 28.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (243 papers), Immunotherapy and Immune Responses (117 papers), T-cell and B-cell Immunology (90 papers), Monoclonal and Polyclonal Antibodies Research (70 papers), Virus-based gene therapy research (51 papers), Immune Response and Inflammation (39 papers), Macrophage Migration Inhibitory Factor (36 papers) and CAR-T cell therapy research (33 papers). The work is most often cited by research in Immunology (18.7k citations), Oncology (7.0k citations) and Biological Psychiatry (374 citations). Ronald B. Herberman has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Howard T. Holden, John R. Ortaldo, Myrthel E. Nunn, Theresa L. Whiteside, David H. Lavrin, Julie Y. Djeu, Guy D. Bonnard, Holger Kirchner, Nikola L. Vujanović and William H. West.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact